Guardian Pharmacy Services, Inc. (NYSE:GRDN) Insider Kendall Forbes Sells 64,991 Shares

Guardian Pharmacy Services, Inc. (NYSE:GRDN) insider Kendall Forbes sold 64,991 shares of the firm’s stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total transaction of $1,310,218.56. Following the completion of the transaction, the insider now directly owns 203,906 shares in the company, valued at $4,110,744.96. This represents a 24.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Kendall Forbes also recently made the following trade(s):

• On Tuesday, May 27th, Kendall Forbes sold 350,058 shares of Guardian Pharmacy Services stock. The stock was sold at an average price of $20.16, for a total transaction of $7,057,169.28.

Guardian Pharmacy Services Price Performance

Shares of NYSE:GRDN opened at $21.37 on Friday. Guardian Pharmacy Services, Inc. has a 12 month low of $14.16 and a 12 month high of $26.91. The stock’s 50 day moving average price is $23.14 and its 200 day moving average price is $22.00.

Guardian Pharmacy Services (NYSE:GRDN) last announced its earnings results on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.22 by ($0.01). The company had revenue of $329.31 million during the quarter, compared to analysts’ expectations of $321.21 million. Research analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

GRDN has been the topic of a number of recent analyst reports. Truist Financial reaffirmed a “buy” rating and set a $28.00 price target (up previously from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Raymond James set a $28.00 price target on Guardian Pharmacy Services and gave the company an “outperform” rating in a report on Wednesday, May 14th. Finally, Wall Street Zen cut Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a report on Saturday, May 24th.

Institutional Investors Weigh In On Guardian Pharmacy Services

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. raised its holdings in Guardian Pharmacy Services by 4.9% during the fourth quarter. Envestnet Asset Management Inc. now owns 12,010 shares of the company’s stock worth $243,000 after purchasing an additional 564 shares in the last quarter. LPL Financial LLC raised its holdings in Guardian Pharmacy Services by 4.8% during the fourth quarter. LPL Financial LLC now owns 17,679 shares of the company’s stock worth $358,000 after purchasing an additional 807 shares in the last quarter. GAMMA Investing LLC bought a new stake in Guardian Pharmacy Services during the first quarter worth approximately $170,000. Lazard Asset Management LLC raised its holdings in Guardian Pharmacy Services by 0.5% during the fourth quarter. Lazard Asset Management LLC now owns 190,797 shares of the company’s stock worth $3,865,000 after purchasing an additional 860 shares in the last quarter. Finally, R Squared Ltd bought a new stake in Guardian Pharmacy Services during the fourth quarter worth approximately $30,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.